XORTX Therapeutics, Inc. (XRTX)
2.39
+0.11
(+4.82%)
USD |
NASDAQ |
Sep 09, 09:58
XORTX Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.0118 |
| December 31, 2025 | 0.0179 |
| September 30, 2025 | 0.0299 |
| June 30, 2025 | 0.0396 |
| March 31, 2025 | 0.0057 |
| December 31, 2024 | 0.0116 |
| September 30, 2024 | 0.0288 |
| June 30, 2024 | 0.0309 |
| March 31, 2024 | 0.0056 |
| December 31, 2023 | 0.0025 |
| September 30, 2023 | 0.0047 |
| June 30, 2023 | 0.0061 |
| March 31, 2023 | 0.0068 |
| December 31, 2022 | 0.0111 |
| September 30, 2022 | 0.0118 |
| June 30, 2022 | 0.012 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.0241 |
| December 31, 2019 | -0.24 |
| September 30, 2019 | -0.4849 |
| June 30, 2019 | 2.278 |
| March 31, 2019 | 0.2782 |
| December 31, 2018 | 0.1347 |
| September 30, 2018 | 0.0899 |
| June 30, 2018 | 0.0534 |
| March 31, 2018 | 0.0381 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Lexaria Bioscience Corp. | 0.0183 |
| InMed Pharmaceuticals, Inc. | 0.061 |
| Target Group, Inc. (Canada) | -1.291 |
| NervGen Pharma Corp. | 0.00 |
| Milestone Pharmaceuticals, Inc. | 7.785 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.184M |
| Total Liabilities (Quarterly) | 0.6795M |
| Shareholders Equity (Quarterly) | 5.505M |
| Current Ratio | 3.586 |
| Net Debt Paydown Yield | 0.08% |